Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Bath & Body Works, Inc.BBWI · Entity 4091 | Chief Financial Officer | March 12, 2026 | March 16, 2026 |
| CVS HEALTH CorpCVS · Entity 2884 | EVP & CFO | May 04, 2021 | May 06, 2021 |
| Cencora, Inc.COR · Entity 2994 | Chief Financial Officer | June 29, 2026 | June 30, 2026 |
| UNITED PARCEL SERVICE INCUPS · Entity 2301 | Director | May 07, 2026 | May 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Bath & Body Works, Inc.
Report date March 12, 2026 · Filed March 16, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.50 par valueSEC Table I · non-derivative | Direct | 223,459 |
Ending reported balance
After 2026-03-13 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-03-12 · Grant · Acquired 115,815 · Balance 234,241 F1: Annual grant of restricted stock units vesting 30% on the first anniversary of March 12, 2026 (the "Grant Date"), 30% on the second anniversary of the Grant Date and 40% on the third anniversary of the Grant Date. Row 2 · 2026-03-13 · Tax withholding · Disposed 10,782 · Balance 223,459 F2: Represents shares withheld in connection with the vesting of restricted stock units to cover tax withholding obligations. |
Filing footnotes · ownership attribution and instrument terms
F1: Annual grant of restricted stock units vesting 30% on the first anniversary of March 12, 2026 (the "Grant Date"), 30% on the second anniversary of the Grant Date and 40% on the third anniversary of the Grant Date.
F2: Represents shares withheld in connection with the vesting of restricted stock units to cover tax withholding obligations.
CVS HEALTH Corp
Report date May 04, 2021 · Filed May 06, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 115,331.0445 |
Reported balance
After 2021-05-04 transaction · row 1
1 source rowRow 1 · 2021-05-04 · Sale · Disposed 4,905 · Balance 115,331.0445 F1: All sales were effected pursuant to a Rule 10b5-1 plan. |
| Common Stock (restricted)SEC Table I · non-derivative | Direct | 2,242 |
Reported balance
Holding disclosure · report date 2021-05-04 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 2,242 |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $102.26 · Expires 2022-04-01 | Direct | 27,392 |
Reported balance
Holding disclosure · report date 2021-05-04 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 27,392 F2: Option became exercisable in four equal annual installments, commencing 4/1/2016. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $104.82 · Expires 2023-04-01 | Direct | 21,509 |
Reported balance
Holding disclosure · report date 2021-05-04 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 21,509 F3: Option becomes exercisable in four equal annual installments, commencing 4/1/2017. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $78.05 · Expires 2024-04-03 | Direct | 35,062 |
Reported balance
Holding disclosure · report date 2021-05-04 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 35,062 F4: Option became exercisable in four equal annual installments, commencing 4/3/2018. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $62.21 · Expires 2025-04-01 | Direct | 35,030 |
Reported balance
Holding disclosure · report date 2021-05-04 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 35,030 F5: Option became exercisable in four equal annual installments, commencing 4/1/2019. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $54.19 · Expires 2029-04-01 | Direct | 202,007 |
Reported balance
Holding disclosure · report date 2021-05-04 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 202,007 F6: Option became exercisable in four equal annual installments, commencing 4/1/2020. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $58.34 · Expires 2030-04-01 | Direct | 168,956 |
Reported balance
Holding disclosure · report date 2021-05-04 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 168,956 F7: The number of shares subject to the option were calculated using a 30-day average price. F8: Options became exercisable in four equal annual installments, commencing 4/1/2021. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $74.30 · Expires 2031-04-01 | Direct | 103,663 |
Reported balance
Holding disclosure · report date 2021-05-04 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance 103,663 F9: Option becomes exercisable in four equal annual installments, commencing 4/1/2022. |
Filing footnotes · ownership attribution and instrument terms
F1: All sales were effected pursuant to a Rule 10b5-1 plan.
F2: Option became exercisable in four equal annual installments, commencing 4/1/2016.
F3: Option becomes exercisable in four equal annual installments, commencing 4/1/2017.
F4: Option became exercisable in four equal annual installments, commencing 4/3/2018.
F5: Option became exercisable in four equal annual installments, commencing 4/1/2019.
F6: Option became exercisable in four equal annual installments, commencing 4/1/2020.
F7: The number of shares subject to the option were calculated using a 30-day average price.
F8: Options became exercisable in four equal annual installments, commencing 4/1/2021.
F9: Option becomes exercisable in four equal annual installments, commencing 4/1/2022.
Cencora, Inc.
Report date June 29, 2026 · Filed June 30, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 21,304 |
Reported balance
After 2026-06-29 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-29 · Grant · Acquired 21,304 · Balance 21,304 F1: Grant of restricted stock units received for no consideration that vest in three equal annual installments on 6/29/2027, 6/29/2028, and 6/29/2029. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of restricted stock units received for no consideration that vest in three equal annual installments on 6/29/2027, 6/29/2028, and 6/29/2029.
UNITED PARCEL SERVICE INC
Report date May 07, 2026 · Filed May 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 9,948.8064 |
Reported balance
After 2026-05-07 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-05-07 · Grant · Acquired 1,948 · Balance 9,948.8064 F1: One unit is equivalent to one share of UPS Class A common stock. F2: Restricted stock units convert into shares of UPS Class A common stock on a one for one basis upon termination of service as a director. F3: Includes units credited upon the payment of dividends on the underlying Class A common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: One unit is equivalent to one share of UPS Class A common stock.
F2: Restricted stock units convert into shares of UPS Class A common stock on a one for one basis upon termination of service as a director.
F3: Includes units credited upon the payment of dividends on the underlying Class A common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 29, 2026 Filed Jun 30, 2026 20:20 UTC | Cencora, Inc. COR · Entity 2994 | GrantRestricted Stock Units · Derivative | 21,304 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001580827-26-000005 · wk-form4_1782850807.xml · derivative · entry 1 Boratto Eva C · CIK 0001580827 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,304 Underlying: Common Stock · 21,304 shares Expires not disclosed F1 · derivative.exercise_price: Grant of restricted stock units received for no consideration that vest in three equal annual installments on 6/29/2027, 6/29/2028, and 6/29/2029. F1 · price: Grant of restricted stock units received for no consideration that vest in three equal annual installments on 6/29/2027, 6/29/2028, and 6/29/2029. F1 · derivative.exercise_date: Grant of restricted stock units received for no consideration that vest in three equal annual installments on 6/29/2027, 6/29/2028, and 6/29/2029. F1 · derivative.expiration_date: Grant of restricted stock units received for no consideration that vest in three equal annual installments on 6/29/2027, 6/29/2028, and 6/29/2029. Read SEC document |
| May 07, 2026 Filed May 8, 2026 20:31 UTC | UNITED PARCEL SERVICE INC UPS · Entity 2301 | GrantRestricted Stock Units · Derivative | 1,948 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-005030 · doc4.xml · derivative · entry 1 Boratto Eva C · CIK 0001580827 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,948.8064 Underlying: Class A Common Stock · 1,948 shares Expires not disclosed F1 · derivative.exercise_price: One unit is equivalent to one share of UPS Class A common stock. F2 · derivative.exercise_date: Restricted stock units convert into shares of UPS Class A common stock on a one for one basis upon termination of service as a director. F2 · derivative.expiration_date: Restricted stock units convert into shares of UPS Class A common stock on a one for one basis upon termination of service as a director. F3 · balance_after: Includes units credited upon the payment of dividends on the underlying Class A common stock. Read SEC document |
| March 13, 2026 Filed Mar 16, 2026 22:24 UTC | Bath & Body Works, Inc. BBWI · Entity 4091 | Tax withholdingCommon Stock, $0.50 par value | 10,782 | $19.50 | $210,249.00 |
DisclosureSEC source: 0001225208-26-003711 · doc4.xml · nonDerivative · entry 2 Boratto Eva C · CIK 0001580827 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 223,459 F2 · shares: Represents shares withheld in connection with the vesting of restricted stock units to cover tax withholding obligations. Read SEC document |
| March 12, 2026 Filed Mar 16, 2026 22:24 UTC | Bath & Body Works, Inc. BBWI · Entity 4091 | GrantCommon Stock, $0.50 par value | 115,815 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-003711 · doc4.xml · nonDerivative · entry 1 Boratto Eva C · CIK 0001580827 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 234,241 F1 · shares: Annual grant of restricted stock units vesting 30% on the first anniversary of March 12, 2026 (the "Grant Date"), 30% on the second anniversary of the Grant Date and 40% on the third anniversary of the Grant Date. Read SEC document |
| August 01, 2025 Filed Aug 5, 2025 20:12 UTC | Bath & Body Works, Inc. BBWI · Entity 4091 | Tax withholdingCommon Stock, $0.50 par value | 6,533 | $28.17 | $184,034.61 |
DisclosureSEC source: 0001225208-25-007016 · doc4.xml · nonDerivative · entry 1 Boratto Eva C · CIK 0001580827 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 118,426 F1 · shares: Represents shares withheld in connection with the vesting of restricted stock units to cover tax withholding obligations. Read SEC document |
| May 08, 2025 Filed May 9, 2025 20:08 UTC | UNITED PARCEL SERVICE INC UPS · Entity 2301 | GrantRestricted Stock Units · Derivative | 2,011 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-004903 · doc4.xml · derivative · entry 1 Boratto Eva C · CIK 0001580827 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,483.4839 Underlying: Class A Common Stock · 2,011 shares Expires not disclosed F1 · derivative.exercise_price: One unit is equivalent to one share of UPS Class A common stock. F2 · derivative.exercise_date: Restricted Stock Units (RSUs) convert into shares of UPS Class A common stock on a one for one basis upon termination of service as a director. F2 · derivative.expiration_date: Restricted Stock Units (RSUs) convert into shares of UPS Class A common stock on a one for one basis upon termination of service as a director. F3 · balance_after: Includes units credited upon the payment of dividends on the underlying Class A common stock. Read SEC document |
| March 13, 2025 Filed Mar 14, 2025 21:06 UTC | Bath & Body Works, Inc. BBWI · Entity 4091 | GrantCommon Stock, $0.50 par value | 50,088 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-003416 · doc4.xml · nonDerivative · entry 2 Boratto Eva C · CIK 0001580827 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,959 Read SEC document |
| March 12, 2025 Filed Mar 14, 2025 21:06 UTC | Bath & Body Works, Inc. BBWI · Entity 4091 | Tax withholdingCommon Stock, $0.50 par value | 2,742 | $28.45 | $78,009.90 |
DisclosureSEC source: 0001225208-25-003416 · doc4.xml · nonDerivative · entry 1 Boratto Eva C · CIK 0001580827 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,871 Read SEC document |
| August 01, 2024 Filed Aug 5, 2024 22:09 UTC | Bath & Body Works, Inc. BBWI · Entity 4091 | Tax withholdingCommon Stock, $0.50 par value | 6,997 | $35.13 | $245,804.61 |
DisclosureSEC source: 0001225208-24-007872 · doc4.xml · nonDerivative · entry 1 Boratto Eva C · CIK 0001580827 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,613 Read SEC document |
| May 02, 2024 Filed May 3, 2024 20:20 UTC | UNITED PARCEL SERVICE INC UPS · Entity 2301 | GrantRestricted Stock Units · Derivative | 1,256 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-005545 · doc4.xml · derivative · entry 1 Boratto Eva C · CIK 0001580827 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,201.0021 Underlying: Class A Common Stock · 1,256 shares Expires not disclosed F1 · derivative.exercise_price: One unit is equivalent to one share of UPS Class A common stock. F2 · derivative.exercise_date: Restricted Stock Units (RSUs) convert into shares of UPS Class A common stock on a one for one basis upon termination of service as a director. F2 · derivative.expiration_date: Restricted Stock Units (RSUs) convert into shares of UPS Class A common stock on a one for one basis upon termination of service as a director. F3 · balance_after: Includes units credited upon the payment of dividends on the underlying Class A common stock. Read SEC document |
| March 13, 2024 Filed Mar 15, 2024 20:42 UTC | Bath & Body Works, Inc. BBWI · Entity 4091 | GrantCommon Stock, $0.50 par value | 29,560 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-004269 · doc4.xml · nonDerivative · entry 1 Boratto Eva C · CIK 0001580827 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,061 Read SEC document |
| March 13, 2024 Filed Mar 19, 2024 21:21 UTC Amendment | Bath & Body Works, Inc. BBWI · Entity 4091 | GrantCommon Stock, $0.50 par value | 30,109 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-004331 · doc4a.xml · nonDerivative · entry 1 Boratto Eva C · CIK 0001580827 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,610 F1 · shares: Due to an inadvertent administrative error by the Company, the securities acquired by the Reporting Person on March 13, 2024 were underreported by 549 shares. This Form 4/A is being filed to report the correct amount of 30,109 shares acquired by the Reporting Person on such date. Read SEC document |
| February 02, 2024 Filed Feb 5, 2024 22:16 UTC | UNITED PARCEL SERVICE INC UPS · Entity 2301 | PurchaseClass B Common Stock | 1,400 | $142.30 | $199,220.00 |
DisclosureSEC source: 0001225208-24-001576 · doc4.xml · nonDerivative · entry 1 Boratto Eva C · CIK 0001580827 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,400 F1 · balance_after: The reporting person holds the shares in an account with their spouse as joint tenants with rights of survivorship. Read SEC document |
| August 01, 2023 Filed Aug 2, 2023 20:31 UTC | Bath & Body Works, Inc. BBWI · Entity 4091 | GrantCommon Stock, $0.50 par value | 54,496 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-007904 · doc4.xml · nonDerivative · entry 1 Boratto Eva C · CIK 0001580827 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,501 Read SEC document |
| May 04, 2023 Filed May 5, 2023 21:19 UTC | UNITED PARCEL SERVICE INC UPS · Entity 2301 | GrantRestricted Stock Units · Derivative | 1,038 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-005492 · doc4.xml · derivative · entry 1 Boratto Eva C · CIK 0001580827 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,789.6404 Underlying: Class A Common Stock · 1,038 shares Expires not disclosed F1 · derivative.exercise_price: One unit is equivalent to one share of UPS Class A common stock. F2 · derivative.exercise_date: Restricted Stock Units (RSUs) convert into shares of UPS Class A common stock on a one for one basis upon termination of service as a director. F2 · derivative.expiration_date: Restricted Stock Units (RSUs) convert into shares of UPS Class A common stock on a one for one basis upon termination of service as a director. F3 · balance_after: Includes units credited upon the payment of dividends on the underlying Class A common stock. Read SEC document |
| May 05, 2022 Filed May 9, 2022 20:17 UTC | UNITED PARCEL SERVICE INC UPS · Entity 2301 | GrantRestricted Stock Units · Derivative | 973 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-006706 · doc4.xml · derivative · entry 1 Boratto Eva C · CIK 0001580827 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,662.5486 Underlying: Class A Common Stock · 973 shares Expires not disclosed F1 · derivative.exercise_price: One unit is equivalent to one share of UPS Class A common stock. F2 · derivative.exercise_date: Restricted Stock Units (RSUs) convert into shares of UPS Class A common stock on a one for one basis upon termination of service as a director. F2 · derivative.expiration_date: Restricted Stock Units (RSUs) convert into shares of UPS Class A common stock on a one for one basis upon termination of service as a director. F3 · balance_after: Includes units credited upon the payment of dividends on the underlying Class A common stock. Read SEC document |
| May 13, 2021 Filed May 17, 2021 21:38 UTC | UNITED PARCEL SERVICE INC UPS · Entity 2301 | GrantRestricted Stock Units · Derivative | 811 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-008225 · doc4.xml · derivative · entry 1 Boratto Eva C · CIK 0001580827 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,652.1939 Underlying: Class A Common Stock · 811 shares Expires not disclosed F1 · derivative.exercise_price: One unit is equivalent to one share of UPS Class A common stock. F2 · derivative.exercise_date: Restricted Stock Units (RSUs) convert into shares of UPS Class A common stock on a one for one basis upon termination of service as a director. F2 · derivative.expiration_date: Restricted Stock Units (RSUs) convert into shares of UPS Class A common stock on a one for one basis upon termination of service as a director. F3 · balance_after: Includes units credited upon the payment of dividends on the underlying Class A common stock. Read SEC document |
| May 04, 2021 Filed May 6, 2021 21:52 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 4,905 | $80.00 | $392,400.00 |
DisclosureSEC source: 0001127602-21-015775 · form4.xml · nonDerivative · entry 1 Boratto Eva C · CIK 0001580827 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,331.0445 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| April 01, 2021 Filed Apr 2, 2021 21:00 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 103,663 | $74.30 Strike: $74.30 | $7,702,160.90 |
DisclosureSEC source: 0001127602-21-012695 · form4.xml · derivative · entry 5 Boratto Eva C · CIK 0001580827 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,663 Underlying: Common Stock · 103,663 shares Expires 2031-04-01 F4 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2022. Read SEC document |
| April 01, 2021 Filed Apr 2, 2021 21:00 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 649 | $74.30 | $48,220.70 |
DisclosureSEC source: 0001127602-21-012695 · form4.xml · nonDerivative · entry 3 Boratto Eva C · CIK 0001580827 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,236.0445 F3 · shares: Surrender of shares in payment of taxes due upon the vesting and settlement of a restricted stock unit award on April 1, 2021. Read SEC document |
| April 01, 2021 Filed Apr 2, 2021 21:00 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 40,128 | $74.30 | $2,981,510.40 |
DisclosureSEC source: 0001127602-21-012695 · form4.xml · nonDerivative · entry 2 Boratto Eva C · CIK 0001580827 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,454.0445 F2 · shares: Surrender of shares in payment of taxes due upon the vesting and settlement of the PSUs on April 1, 2021. Read SEC document |
| March 16, 2021 Filed Mar 17, 2021 21:22 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 18,882 | $0.00 Strike: $74.29 | $0.00 |
DisclosureSEC source: 0001127602-21-011098 · form4.xml · derivative · entry 4 Boratto Eva C · CIK 0001580827 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,882 shares Expires 2021-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2015. Read SEC document |
| March 16, 2021 Filed Mar 17, 2021 21:22 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 18,882 | $74.68 | $1,410,107.76 |
DisclosureSEC source: 0001127602-21-011098 · form4.xml · nonDerivative · entry 2 Boratto Eva C · CIK 0001580827 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,082.0445 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F2 · price: Represents weighted average sale price for this group of sales, which occurred on the same trading day. Multiple sales were executed, with sales prices ranging between $74.49 and $75.00 per share. Read SEC document |
| March 16, 2021 Filed Mar 17, 2021 21:22 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 18,882 | $74.29 | $1,402,743.78 |
DisclosureSEC source: 0001127602-21-011098 · form4.xml · nonDerivative · entry 1 Boratto Eva C · CIK 0001580827 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,964.0445 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2021 Filed Apr 2, 2021 21:00 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 88,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-012695 · form4.xml · nonDerivative · entry 1 Boratto Eva C · CIK 0001580827 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,582.0445 F1 · shares: Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on February 1, 2021. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 1, 2021. The PSUs vested and settled on April 1, 2021. Read SEC document |
| September 10, 2020 Filed Sep 11, 2020 20:09 UTC | UNITED PARCEL SERVICE INC UPS · Entity 2301 | GrantRestricted Stock Units · Derivative | 831 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-011428 · doc4.xml · derivative · entry 1 Boratto Eva C · CIK 0001580827 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 831 Underlying: Class A Common Stock · 831 shares Expires not disclosed F1 · derivative.exercise_price: One unit is equivalent to one share of UPS class A common stock. F2 · derivative.expiration_date: RSUs are fully vested on the date of the grant and are required to be held by the director until he or she separates from the board, at which time the RSUs are paid out in shares of class A common stock. Read SEC document |
| April 03, 2020 Filed Apr 7, 2020 21:44 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 1,017 | $55.72 | $56,667.24 |
DisclosureSEC source: 0001127602-20-013418 · form4.xml · nonDerivative · entry 1 Boratto Eva C · CIK 0001580827 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,745.5255 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 21:22 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 168,956 | $58.61 Strike: $58.61 | $9,902,511.16 |
DisclosureSEC source: 0001127602-20-013225 · form4.xml · derivative · entry 3 Boratto Eva C · CIK 0001580827 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,956 Underlying: Common Stock · 168,956 shares Expires 2030-04-01 F2 · derivative.exercise_price: The number of shares subject to the option were calculated using a 30-day average price. F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2021. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 21:22 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 887 | $58.34 | $51,747.58 |
DisclosureSEC source: 0001127602-20-013225 · form4.xml · nonDerivative · entry 1 Boratto Eva C · CIK 0001580827 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,520.5255 F1 · shares: Surrrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 21:25 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 168,956 | $58.61 Strike: $58.61 | $9,902,511.16 |
DisclosureSEC source: 0001127602-20-013230 · form4.xml · derivative · entry 3 Boratto Eva C · CIK 0001580827 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,956 Underlying: Common Stock · 168,956 shares Expires 2030-04-01 F2 · derivative.exercise_price: The number of shares subject to the option were calculated using a 30-day average price. F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2021. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 21:25 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 887 | $58.34 | $51,747.58 |
DisclosureSEC source: 0001127602-20-013230 · form4.xml · nonDerivative · entry 1 Boratto Eva C · CIK 0001580827 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,520.5255 F1 · shares: Surrrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| April 01, 2020 Filed Apr 7, 2020 21:34 UTC Amendment | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 168,956 | $0.00 Strike: $58.34 | $0.00 |
DisclosureSEC source: 0001127602-20-013404 · form4a.xml · derivative · entry 1 Boratto Eva C · CIK 0001580827 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,956 Underlying: Common Stock · 168,956 shares Expires 2030-04-01 F1 · derivative.exercise_price: This Form 4/A is being filed in order to correct the exercise price (Table II, column 2) for the stock option granted on 4/1/2020, which was reported incorrectly on the original Form 4 due to a clerical error. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 22:35 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 13,193 | $59.18 | $780,761.74 |
DisclosureSEC source: 0001127602-20-009155 · form4.xml · nonDerivative · entry 3 Boratto Eva C · CIK 0001580827 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,451.5255 F3 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of stock awards under the Issuer's 2017 Incentive Compensation Plan and its Long-Term Incentive Plan. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 22:35 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 33,795 | $59.18 | $1,999,988.10 |
DisclosureSEC source: 0001127602-20-009155 · form4.xml · nonDerivative · entry 2 Boratto Eva C · CIK 0001580827 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,644.5255 F2 · shares: Consists of stock awarded at market price pursuant to Issuer's 2017 Incentive Compensation Plan and its Long-Term Incentive Plan. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 22:35 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 137 | $59.18 | $8,107.66 |
DisclosureSEC source: 0001127602-20-009155 · form4.xml · nonDerivative · entry 1 Boratto Eva C · CIK 0001580827 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,849.5255 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| September 12, 2019 Filed Sep 13, 2019 21:09 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 8,852 | $0.00 Strike: $54.53 | $0.00 |
DisclosureSEC source: 0001127602-19-028354 · form4.xml · derivative · entry 4 Boratto Eva C · CIK 0001580827 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,852 shares Expires 2020-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2014. Read SEC document |
| September 12, 2019 Filed Sep 13, 2019 21:09 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 8,130 | $65.00 | $528,450.00 |
DisclosureSEC source: 0001127602-19-028354 · form4.xml · nonDerivative · entry 2 Boratto Eva C · CIK 0001580827 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,142.9627 F1 · shares: All sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise, with shares sold to cover the option exercise price and taxes, and the Reporting Person retaining all remaining shares. Read SEC document |
| September 12, 2019 Filed Sep 13, 2019 21:09 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 8,852 | $54.53 | $482,699.56 |
DisclosureSEC source: 0001127602-19-028354 · form4.xml · nonDerivative · entry 1 Boratto Eva C · CIK 0001580827 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,272.9627 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 20:50 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 202,007 | $54.19 Strike: $54.19 | $10,946,759.33 |
DisclosureSEC source: 0001127602-19-014654 · form4.xml · derivative · entry 3 Boratto Eva C · CIK 0001580827 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 202,007 Underlying: Common Stock · 202,007 shares Expires 2029-04-01 F2 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2020. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 20:50 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 1,336 | $54.19 | $72,397.84 |
DisclosureSEC source: 0001127602-19-014654 · form4.xml · nonDerivative · entry 1 Boratto Eva C · CIK 0001580827 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,420.9627 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a stock award under an incentive compensation plan. Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 22:40 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 1,893 | $57.83 | $109,472.19 |
DisclosureSEC source: 0001127602-19-009275 · form4.xml · nonDerivative · entry 2 Boratto Eva C · CIK 0001580827 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,986.9627 F2 · shares: Consists of stock awarded at market price pursuant to Issuer's 2017 Incentive Compensation Plan and its Long-Term Incentive Plan. Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 22:40 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 1,101 | $57.83 | $63,670.83 |
DisclosureSEC source: 0001127602-19-009275 · form4.xml · nonDerivative · entry 1 Boratto Eva C · CIK 0001580827 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,093.9627 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of restricted stock awards under the Issuer's 2017 Incentive Compensation Plan and its Long-Term Incentive Plan. Read SEC document |
| October 01, 2018 Filed Oct 3, 2018 20:09 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 4,426 | $0.00 Strike: $54.53 | $0.00 |
DisclosureSEC source: 0001127602-18-029362 · form4.xml · derivative · entry 4 Boratto Eva C · CIK 0001580827 · EVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,852 Underlying: Common Stock · 4,426 shares Expires 2020-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2014. Read SEC document |
| October 01, 2018 Filed Oct 3, 2018 20:09 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 4,426 | $80.00 | $354,080.00 |
DisclosureSEC source: 0001127602-18-029362 · form4.xml · nonDerivative · entry 2 Boratto Eva C · CIK 0001580827 · EVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,850.9749 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| October 01, 2018 Filed Oct 3, 2018 20:09 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 4,426 | $54.53 | $241,349.78 |
DisclosureSEC source: 0001127602-18-029362 · form4.xml · nonDerivative · entry 1 Boratto Eva C · CIK 0001580827 · EVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,276.9749 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 17, 2018 Filed Sep 19, 2018 20:26 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 13,311 | $0.00 Strike: $45.07 | $0.00 |
DisclosureSEC source: 0001127602-18-028061 · form4.xml · derivative · entry 3 Boratto Eva C · CIK 0001580827 · EVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,311 shares Expires 2019-04-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/2/2013. Read SEC document |
| September 17, 2018 Filed Sep 19, 2018 20:26 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 13,311 | $77.16 | $1,027,076.76 |
DisclosureSEC source: 0001127602-18-028061 · form4.xml · nonDerivative · entry 2 Boratto Eva C · CIK 0001580827 · EVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,850.9749 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F2 · price: Represents weighted average sale price for this group of sales, which occurred on the same trading day. Multiple sales were executed, with sales prices ranging between $76.77 and $77.93 per share. Read SEC document |
| September 17, 2018 Filed Sep 19, 2018 20:26 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 13,311 | $45.07 | $599,926.77 |
DisclosureSEC source: 0001127602-18-028061 · form4.xml · nonDerivative · entry 1 Boratto Eva C · CIK 0001580827 · EVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,161.9749 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2018 Filed Apr 3, 2018 21:29 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 35,030 | $0.00 Strike: $62.21 | $0.00 |
DisclosureSEC source: 0001127602-18-013821 · form4.xml · derivative · entry 3 Boratto Eva C · CIK 0001580827 · EVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,030 Underlying: Common Stock · 35,030 shares Expires 2025-04-01 F2 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2019. Read SEC document |
| April 01, 2018 Filed Apr 3, 2018 21:29 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 594 | $62.21 | $36,952.74 |
DisclosureSEC source: 0001127602-18-013821 · form4.xml · nonDerivative · entry 1 Boratto Eva C · CIK 0001580827 · EVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,850.9749 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a stock award under an incentive compensation plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.